We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

62 hedge funds and large institutions have $2.34M invested in Envoy Medical Warrant in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

3% more funds holding

Funds holding: 60 → 62 (+2)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

19% less capital invested

Capital invested by funds: $2.9M → $2.34M (-$561K)

Holders
62
Holders Change
+2
Holders Change %
+3.33%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
8
Closed
6
Calls
$6.24M
Puts
–
Net Calls
+$6.24M
Net Calls Change
-$24K

Top Buyers

Rank Fund Capital Flow
1
BCL
Bracebridge Capital LLC
Massachusetts
+$14.7K
2
SG
StoneX Group
New York
+$12.8K
3
SRF
Silver Rock Financial
California
+$11.8K
4
BFM
Boothbay Fund Management
New York
+$6.79K
5
ETH
Exos TFP Holdings
New York
+$3.93K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$112K
2
Man Group
Man Group
United Kingdom
-$15.7K
3
BCM
BlueCrest Capital Management
Jersey
-$7.6K
4
RA
Ramius Advisors
New York
-$6.6K
5
CS
Clear Street
New York
-$4.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
Parallax Volatility Advisers
26
Parallax Volatility Advisers
California
$4.66K +$1.76K +31,258 +31%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$4.33K – – –
MC
28
Meteora Capital
Florida
$4.15K – – –
FSI
29
Flow State Investments
Illinois
$3.95K +$281 +5,000 +5%
Goldman Sachs
30
Goldman Sachs
New York
$3.88K – – –
Calamos Advisors
31
Calamos Advisors
Illinois
$3.52K – – –
DCM
32
Dupont Capital Management
Delaware
$3.52K – – –
CF
33
Cantor Fitzgerald
New York
$3.52K – – –
CCA
34
Castle Creek Arbitrage
Colorado
$3.45K – – –
AA
35
AQR Arbitrage
Connecticut
$3.14K – – –
ECP
36
Empyrean Capital Partners
California
$2.64K – – –
CS
37
Clear Street
New York
$2.38K -$4.09K -72,815 -54%
KJHP
38
K.J. Harrison & Partners
Ontario, Canada
$2.21K -$1.41K -25,000 -26%
RA
39
Ramius Advisors
New York
$1.95K -$6.6K -117,428 -69%
TCM
40
Tenor Capital Management
New York
$1.88K – – –
Walleye Capital
41
Walleye Capital
New York
$1.67K +$957 +17,030 +62%
CAC
42
Cowen and Company
New York
$1.48K -$495 -8,807 -18%
AC
43
Ayrton Capital
Connecticut
$1.25K – – –
MTIM
44
Marathon Trading Investment Management
Pennsylvania
$1.02K – – –
PHAM
45
Portland Hill Asset Management
United Kingdom
$1K – – –
CCM
46
CAAS Capital Management
New York
$882 – – –
LCM
47
Landscape Capital Management
New Jersey
$878 +$1.31K +23,345 New
AA
48
Ancora Advisors
Ohio
$864 -$11 -200 -0.8%
OAC
49
OMERS Administration Corp
Ontario, Canada
$821 – – –
GAM
50
Gritstone Asset Management
Maryland
$788 +$280 +4,987 +31%
1
2
3

COCHW Hedge Fund Activity: Q1 2023 in Review

62 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q1 2023, worth a combined $2.34M — down 19% from $2.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new COCHW positions and 6 closed out — a net gain of 2 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Bracebridge Capital LLC, opening a new position worth an estimated $14.7K. The largest seller was Mangrove Partners, exiting entirely with an estimated $112K sold.

  • 62 institutional investors held Envoy Medical Warrant (COCHW) as of Q1 2023, up from 60 in Q4 2022.
  • Funds reported $2.34M of Envoy Medical Warrant stock for Q1 2023, down 19% quarter-over-quarter.
  • 8 funds opened new Envoy Medical Warrant positions in Q1 2023 and 6 closed out, a net change of +2 holders.
  • The largest Envoy Medical Warrant buyer in Q1 2023 was Bracebridge Capital LLC, an estimated $14.7K added.
  • The largest Envoy Medical Warrant seller in Q1 2023 was Mangrove Partners, an estimated $112K sold.

Based on aggregated 13F filings for Q1 2023.